Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD69 | Q07108 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | LGALS3 | P17931 | 6/20 | 0.58 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.58 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.58 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.48 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.48 |
| ▸ | AMY2A | P04746 | 1/20 | 0.47 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29454030 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL29483164 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL30703113 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL4809869 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL9566182 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL4809860 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL16298755 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL9566045 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL9566048 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL30185423 | 1.00 | CD69 (0.61) | CD69ALDH1A1THRBLGALS3LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3341411-B1 | ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOF | ALECTOR LLC (US) | 2025-06-11 | — | — | EP | disclosed |
| US-11359014-B2 | Anti-siglec-5 antibodies and methods of use thereof | ALECTOR LLC (US) | 2022-06-14 | — | — | US | disclosed |
| WO-1999052922-A1 | ANTIMICROBIAL βGalNAc(1→4)βGal DERIVATIVES AND METHODS OF USE | HELIX BIOPHARMA CORP. (CA) | 1999-10-21 | — | — | WO | disclosed |